Immunomodulatory endothelial cells contribute to T cell recruitment and activation via antigen presentation on MHC II
Clicks: 3
ID: 319084
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.6
/100
3 views
2 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #94 of 104 articles by views in cardiovascular research
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
AIMS: A subset of endothelial cells referred to as immunomodulatory endothelial cells (IMEC) has been proposed to regulate T cell responses in atherosclerosis and after myocardial infarction. Here, we studied the inflammation-induced emergence of IMEC and characterized their crosstalk with T cells. METHODS AND RESULTS: An in vitro model to study IMEC was characterized using flow cytometry and proteomics. Endothelial cell-specific translatome and single cell transcriptome data from a murine atherogenesis model and single-cell transcriptome data from human atherosclerotic arteries were used to determine pathophysiological relevance. Immunopeptidomics was performed to detect antigen presentation. T cell chemotaxis, adhesion and activation were assessed through flow cytometry and microscopy. IMEC were induced by treating human endothelial cells with interleukin-1β, interferon-γ and transforming growth factor-β2 and expressed lower levels of classical endothelial cell markers and disrupted VE-cadherin expression accompanied by impaired barrier function. IMEC expressed major histocompatibility complex (MHC) class II, proteins involved in antigen processing and presentation (CD83, CD80 and CD86) and pro-inflammatory cytokines as well as chemokines, including CXCL9. An IMEC-like subpopulation was identified in the lumen of carotid arteries in a mouse model of accelerated atherogenesis as well as in human atheromas. Conditioned medium from IMEC enhanced the migration of peripheral blood mononuclear cells and induced T cell chemotaxis, which was partially inhibited by antagonizing CXCL9. IMEC exhibited a significant downregulation of proteins related to glycosaminoglycan degradation, consistent with the key role of the glycocalyx in the establishment of chemokine gradients. Indeed, the accumulation of heparan sulfates in IMEC contributed to the adhesion of T cells. Notably, IMEC that had been exposed to monocyte lysates presented 627 peptide antigens on MHC class II and induced T cell expansion. CONCLUSION: Our data highlight the role of IMEC as non-professional antigen-presenting cells that potentially contribute to T cell-mediated immune responses in cardiovascular disease.
| Reference Key |
openalex_W7166505464
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Matteo Cartura, Blerina Aliraj, Witold Szymanski, C.-S. Park, Giulio Ferrario, Flávia Rezende, Beyza Güven, Tore Bleckwehl, Nadja Sachs, Lars Mägdefessel, Stefanie Dimmeler, Oliver J. Müller, Hanjoong Jo, Stefan Offermanns, Sikander Hayat, R Brandes, Christian Münch, Johannes Graumann, Andreas Weigert, Ingrid Fleming, Mauro Siragusa |
| Journal | cardiovascular research |
| Year | 2026 |
| DOI |
10.1093/cvr/cvag137
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.